ADCOCK INGRAM HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.62 ZAR | +1.83% |
|
+2.95% | -5.79% |
| Feb. 21 | Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 21 | Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024 |
ETFs positioned on Adcock Ingram Holdings Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 0 M€ | +3.95% | - | |
| 0.00% | 0 M€ | +3.63% | - |
Adcock Ingram Holdings Limited is one of South Africa's largest pharmaceutical groups. The group also provides hospital products. Net sales break down by family of products as follows:
- pharmaceutical products (79.2%): OTC medicines, prescription products, etc.;
- hospital products (20.8%; No. 1 in South Africa).
At the end of June 2023, the group had 3 production sites located in South Africa.
France accounts for 98.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q4 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
56.5
ZAR
Average target price
56
ZAR
Spread / Average Target
-0.88%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.79% | 452M | |
| +19.62% | 43.27B | |
| +24.52% | 22.92B | |
| +20.29% | 15.43B | |
| +7.48% | 12.95B | |
| +42.51% | 11.83B | |
| -8.84% | 6.91B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.55B |
- Stock Market
- Equities
- AIP Stock
- Funds and ETFs Adcock Ingram Holdings Limited